Bayer
13 articles related to "Bayer"
-
BBC: Do drugs really have to be so expensive?
A liver cancer treatment is off-limits in the NHS due to its unjustifiably high price tag, but in India the same treatment is available for less than £100 a month. In this week's Scrubbing...
Op-eds & Articles – Last updated 28 March 2013
msfaccess.org/content/bbc-do-drugs-really-have-be-so-expensive -
India upholds compulsory licence on cancer drug in Bayer case appeal
New Delhi/Geneva, 4 March 2013 – The verdict into German pharmaceutical company Bayer’s appeal against the grant of a compulsory licence has been issued by India’s Intellectual Property...
Statements, Speeches, Letters – Last updated 04 March 2013
msfaccess.org/content/india-upholds-compulsory-licence-cancer-drug-bayer-case-appeal -
Final hearings begin in Bayer's appeal against Indian move to allow production of more affordable cancer drug
Further compulsory licences on high-price patented medicines expected 18 January 2013 - This week, final hearings began in Chennai, India, in the appeal that German pharmaceutical company Bayer...
Statements, Speeches, Letters – Last updated 18 January 2013
msfaccess.org/content/final-hearings-begin-bayers-appeal-against-indian-move-allow-production-more-affordable -
MSF statement on India's dismissal of Bayer's request for a stay on compulsory licence
17 September 2012 - India's Intellectual Property Appellate Board (IPAB) has dismissed Bayer’s request for a stay order against the compulsory licence granted by the Patent Controller...
Statements, Speeches, Letters – Last updated 17 September 2012
msfaccess.org/content/msf-statement-indias-dismissal-bayers-request-stay-compulsory-licence -
Bayer attempts block on affordable patented drugs in India
German company appeals against life-saving compulsory licence decision in India Geneva/New Delhi, 3 September, 2012 – German pharmaceutical company Bayer today heads to India’s Intellectual...
Press Release – Last updated 26 September 2012
msfaccess.org/about-us/media-room/press-releases/bayer-attempts-block-affordable-patented-drugs-india -
Infographics: Big pharma's continued attack on India, 'pharmacy of the developing world'
Novartis and Bayer are both charging exhorbitant prices for medicines in India as they continue their fight against the country's patent law that puts people over profits in the name of access to...
Web article – Last updated 11 September 2012
msfaccess.org/content/infographics-big-pharmas-continued-attack-india-pharmacy-developing-world -
Bayer/Natco compulsory licence appeal – hearings postponed
Médecins Sans Frontières (MSF) has learnt that India's Intellectual Property Appellate Board (IPAB) in Chennai has postponed hearing the appeal by German pharmaceutical company Bayer...
Statements, Speeches, Letters – Last updated 21 August 2012
msfaccess.org/content/bayernatco-compulsory-licence-appeal-%E2%80%93-hearings-postponed -
UPDATE: Intellectual Property Battles Continue in India; Novartis Trial Further Delayed
Médecins Sans Frontières (MSF) has learnt this morning that final arguments in the Indian Supreme Court case of Novartis vs. Government of India has been re-scheduled for 11 September...
Web article – Last updated 22 August 2012
msfaccess.org/content/update-intellectual-property-battles-continue-india-novartis-trial-further-delayed -
Background Information on India's First Compulsory Licence
India grants first Compulsory licence to allow generic production and sale of a patented medicine The compulsory licence was granted under Section 90 of the Indian Patents Act, on 12th March 2012...
Web article – Last updated 10 April 2012
msfaccess.org/content/background-information-indias-first-compulsory-licence -
India Issues First Compulsory Licence
Groundbreaking Move Sets Precedent for Overcoming Drug Price Barriers India 2008 © Jean-Marc Giboux/Getty Images 12 March 2012, New Delhi/Geneva – In a landmark case, the Indian...
Press Release – Last updated 12 April 2012
msfaccess.org/about-us/media-room/press-releases/india-issues-first-compulsory-licence
